Natures Sunshine Products Inc (NATR)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ
Market Cap: $179.53M
Last updated: Nov 17, 2026 at 11:03 AM ET
Natures Sunshine Products Inc (NATR) Earnings: Report Dates and Results
Natures Sunshine Products (NATR) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Natures Sunshine Products reported EPS of $0.14, below the $0.25 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NATR has an expected report date of Mar 8, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 56.7% below the $0.30 reported for the quarter ended Dec 31, 2025.
NATR Earnings Call
The latest NATR earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 25 quarters below that had an estimate, NATR beat 15, missed 8 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $116.60M, down 9.1% from $128.34M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.14 | $0.25 | $0.21 - $0.29 | -44.00% | Miss | -61.1% | 2 | 0 up, 1 down | Nov 4, 2026 | $116.60M |
| Jun 30, 2026 | $0.21 | $0.27 | $0.25 - $0.29 | -22.22% | Miss | -40.0% | 2 | 0 up, 2 down | Aug 6, 2026 | $116.98M |
| Mar 31, 2026 | $0.30 | $0.21 | $0.16 - $0.29 | +42.86% | Beat | +20.0% | 2 | 2 up, 0 down | May 7, 2026 | $122.89M |
| Dec 31, 2025 | $0.30 | $0.21 | $0.16 - $0.21 | +44.30% | Beat | N/A | 2 | 0 up, 1 down | Mar 10, 2026 | $123.81M |
| Sep 30, 2025 | $0.36 | $0.16 | $0.15 - $0.17 | +125.00% | Beat | +33.3% | 2 | 0 up, 1 down | Nov 6, 2025 | $128.34M |
| Jun 30, 2025 | $0.35 | $0.16 | $0.14 - $0.18 | +118.75% | Beat | +400.0% | 2 | 0 up, 2 down | Jul 31, 2025 | $114.75M |
| Mar 31, 2025 | $0.25 | $0.17 | $0.16 - $0.17 | +47.06% | Beat | +108.3% | 2 | 0 up, 2 down | May 6, 2025 | $113.25M |
| Dec 31, 2024 | -$0.02 | $0.20 | $0.19 - $0.21 | -108.70% | Miss | -103.9% | 2 | 1 up, 0 down | Mar 11, 2025 | $118.20M |
| Sep 30, 2024 | $0.27 | $0.14 | $0.14 - $0.14 | +92.86% | Beat | +80.0% | 2 | 0 up, 0 down | Nov 7, 2024 | $114.61M |
| Jun 30, 2024 | $0.07 | $0.18 | N/A | -61.11% | Miss | -41.7% | N/A | 0 up, 0 down | Aug 8, 2024 | $110.55M |
| Mar 31, 2024 | $0.12 | $0.17 | $0.17 - $0.17 | -29.41% | Miss | -47.8% | 1 | 0 up, 0 down | May 7, 2024 | $110.99M |
| Dec 31, 2023 | $0.45 | $0.15 | $0.15 - $0.15 | +200.00% | Beat | +350.0% | 1 | 0 up, 0 down | Mar 12, 2024 | $108.94M |
| Sep 30, 2023 | $0.15 | $0.13 | N/A | +15.38% | Beat | N/A | N/A | 0 up, 0 down | Nov 7, 2023 | $111.20M |
| Jun 30, 2023 | $0.12 | $0.03 | $0.03 - $0.03 | +300.00% | Beat | +300.0% | 1 | 0 up, 0 down | Aug 9, 2023 | $116.55M |
| Mar 31, 2023 | $0.23 | -$0.01 | -$0.01 - -$0.01 | N/A | N/A | N/A | 1 | 0 up, 0 down | May 9, 2023 | $108.63M |
| Dec 31, 2022 | $0.10 | -$0.04 | -$0.04 - -$0.04 | +350.00% | Beat | -85.3% | 1 | 0 up, 0 down | Mar 15, 2023 | $102.75M |
| Sep 30, 2022 | -$0.06 | $0.10 | $0.10 - $0.10 | -160.00% | Miss | -128.6% | 1 | 0 up, 0 down | Nov 3, 2022 | $104.51M |
| Jun 30, 2022 | $0.03 | -$0.06 | -$0.06 - -$0.06 | +150.00% | Beat | -90.6% | 1 | 0 up, 0 down | Aug 9, 2022 | $104.16M |
| Mar 31, 2022 | -$0.03 | $0.27 | N/A | -111.11% | Miss | -114.3% | N/A | 0 up, 0 down | May 5, 2022 | $110.49M |
| Dec 31, 2021 | $0.68 | $0.09 | $0.09 - $0.09 | +655.56% | Beat | +134.5% | 1 | 0 up, 0 down | Mar 8, 2022 | $117.94M |
| Sep 30, 2021 | $0.21 | $0.18 | N/A | +16.67% | Beat | N/A | N/A | N/A | Nov 4, 2021 | $114.75M |
| Jun 30, 2021 | $0.32 | $0.32 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 5, 2021 | $108.98M |
| Mar 31, 2021 | $0.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 6, 2021 | $102.42M |
| Dec 31, 2020 | $0.29 | N/A | N/A | N/A | N/A | +480.0% | N/A | N/A | Mar 10, 2021 | $101.74M |
| Sep 30, 2020 | -$0.98 | N/A | N/A | N/A | N/A | -1325.0% | N/A | N/A | Nov 9, 2020 | $100.25M |
| Jun 30, 2020 | -$0.98 | N/A | N/A | N/A | N/A | -753.3% | N/A | N/A | Aug 6, 2020 | $87.29M |
| Mar 31, 2020 | -$0.98 | $0.15 | N/A | -753.33% | Miss | -800.0% | N/A | N/A | May 11, 2020 | $95.93M |
| Dec 31, 2019 | $0.05 | $0.05 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 11, 2020 | $91.69M |
| Sep 30, 2019 | $0.08 | $0.07 | N/A | +14.29% | Beat | 0.0% | N/A | N/A | Nov 7, 2019 | $88.52M |
| Jun 30, 2019 | $0.15 | $0.14 | N/A | +7.14% | Beat | +92.1% | N/A | N/A | Aug 8, 2019 | $90.72M |
| Mar 31, 2019 | $0.14 | N/A | N/A | N/A | N/A | +366.7% | N/A | N/A | May 9, 2019 | $91.27M |
| Dec 31, 2018 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 7, 2019 | $97.37M |
| Sep 30, 2018 | $0.08 | N/A | N/A | N/A | N/A | -38.5% | N/A | N/A | Nov 7, 2018 | $88.83M |
| Jun 30, 2018 | $0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 7, 2018 | $91.27M |
| Mar 31, 2018 | $0.03 | N/A | N/A | N/A | N/A | -72.7% | N/A | N/A | May 10, 2018 | $87.34M |
| Dec 31, 2017 | -$0.98 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 16, 2018 | $88.29M |
| Sep 30, 2017 | $0.13 | N/A | N/A | N/A | N/A | -40.9% | N/A | N/A | Nov 8, 2017 | $89.30M |
| Jun 30, 2017 | -$0.01 | N/A | N/A | N/A | N/A | -107.4% | N/A | N/A | Aug 8, 2017 | $81.34M |
| Mar 31, 2017 | $0.11 | N/A | N/A | N/A | N/A | +1.7% | N/A | N/A | May 10, 2017 | $83.10M |
| Dec 31, 2016 | -$0.35 | N/A | N/A | N/A | N/A | -282.7% | N/A | N/A | Mar 7, 2017 | $83.95M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $1.26, up 184.7% from the year before. It was $0.11 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $1.26 | +184.7% |
| Dec 31, 2024 | $0.44 | -53.4% |
| Dec 31, 2023 | $0.95 | +2275.0% |
| Dec 31, 2022 | $0.04 | -97.2% |
| Dec 31, 2021 | $1.42 | N/A |
| Dec 31, 2020 | -$2.65 | -731.0% |
| Dec 31, 2019 | $0.42 | +227.9% |
| Dec 31, 2018 | $0.13 | N/A |
| Dec 31, 2017 | -$0.75 | -787.4% |
| Dec 31, 2016 | $0.11 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,200 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,200 | 6 | |
| 2026Q2 | Jun 30, 2026 | 3,440 | 6 | |
| 2026Q1 | Mar 31, 2026 | 3,835 | 5 | |
| 2025Q4 | Dec 31, 2025 | 4,502 | 6 | |
| 2025Q3 | Sep 30, 2025 | 4,593 | 6 | |
| 2025Q2 | Jun 30, 2025 | 4,398 | 6 | |
| 2025Q1 | Mar 31, 2025 | 3,880 | 6 | |
| 2024Q3 | Sep 30, 2024 | 3,881 | 6 |
2026Q3 Earnings Call
Opening remarks
Nate Brower General Counsel Thank you, Marissa. Good afternoon, and thanks for joining our conference call to discuss our third quarter 2026 financial results. I'd like to remind everyone that this call is available for replay via telephonic dial-in through November 18 and via a live webcast that will be posted in the investor relations portion of our website at ir.naturessunshine.com. The information on this call contains forward-looking statements. These statements are often characterized by terminology such as hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's annual report on Form 10-K, quarterly reports on Form 10-Q, our earnings release issued today, and other reports filed with the Securities and Exchange Commission. The information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein. Now I would like to turn the call over to the CEO of Nature's Sunshine, Ken Romanzi. Ken?
Ken Romanzi CEO Thank you, Nate, and good afternoon, everyone. Thank you for joining our third quarter earnings call. Simply put, we had a poor quarter that fell well short of our expectations. Nature's Sunshine is a company built for growth, with the tailwinds of the natural supplement category to fuel us. As I celebrate my first-year anniversary with the company, I am convinced now more than ever that we can accelerate our growth well into the future. But our business declined in the quarter, primarily due to soft performance in two areas that have historically been growth engines for us, Asia and North America, and it will take a few quarters to work our way through these issues. Asia declined primarily due to weakness in China, where the unexpected passing of two of our key leaders in one region earlier this year had a greater and more lasting impact than we initially anticipated. In addition, the actions we took in the second quarter to address certain distributor sales practices that were inconsistent with our policies disrupted recruiting and business-building activity among portions of our consultant leadership base. We expect the impact to continue as our consultants adjust their business-building practices and work to rebuild our productive base. Despite this, our long-term outlook in China is positive. China is a very large direct selling and supplement market, and we've had great success building the business there to $40 million in revenue in 2025 with an effective consultant base.
Frequently Asked Questions About NATR
When is Natures Sunshine Products's next earnings date?
Natures Sunshine Products's next earnings report is expected for Mar 8, 2027.
Did NATR beat earnings estimates last quarter?
No. Natures Sunshine Products reported EPS of $0.14 for the quarter ended Sep 30, 2026, below the $0.25 estimate by 44.00%.
What EPS do analysts expect from NATR next quarter?
The consensus EPS estimate for Natures Sunshine Products for the quarter ending Dec 31, 2026 is $0.13 from 4 analysts, with estimates from $0.10 to $0.17.
How often does NATR beat earnings estimates?
Natures Sunshine Products beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +25.38%.
NATR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors